Please login to the form below

Not currently logged in
Email:
Password:

Alios BioPharna

This page shows the latest Alios BioPharna news and features for those working in and with pharma, biotech and healthcare.

Johnson & Johnson to acquire Alios BioPharma for $1.75bn

Johnson & Johnson to acquire Alios BioPharma for $1.75bn

Johnson &Johnson has acquired California-based clinical stage biopharma company Alios BioPharma for $1.75bn. ... The acquisition will include Alios BioPharma's preclinical programmes that target influenza and rhinovirus, as well as RSV.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics